Gensight Biologics SA
PAR:SIGHT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.29
0.704
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Gensight Biologics SA
Current Portion of Long-Term Debt
Gensight Biologics SA
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gensight Biologics SA
PAR:SIGHT
|
Current Portion of Long-Term Debt
€17.4m
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Current Portion of Long-Term Debt
€22.6m
|
CAGR 3-Years
30%
|
CAGR 5-Years
44%
|
CAGR 10-Years
12%
|
|
Nanobiotix SA
PAR:NANO
|
Current Portion of Long-Term Debt
€4.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Innate Pharma SA
PAR:IPH
|
Current Portion of Long-Term Debt
€8.9m
|
CAGR 3-Years
57%
|
CAGR 5-Years
39%
|
CAGR 10-Years
36%
|
|
Genfit SA
NASDAQ:GNFT
|
Current Portion of Long-Term Debt
€7.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
44%
|
|
Eurobio Scientific SA
PAR:ALERS
|
Current Portion of Long-Term Debt
€15m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
37%
|
See Also
What is Gensight Biologics SA's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
17.4m
EUR
Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Current Portion of Long-Term Debt amounts to 17.4m EUR.
What is Gensight Biologics SA's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
80%
Over the last year, the Current Portion of Long-Term Debt growth was 615%. The average annual Current Portion of Long-Term Debt growth rates for Gensight Biologics SA have been 80% over the past three years .